Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating, one has given a buy rating and one has given a strong buy rating to the company.
Several analysts have weighed in on the stock. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. Citigroup restated a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th.
View Our Latest Stock Report on SAUHY
Straumann Price Performance
About Straumann
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Featured Articles
- Five stocks we like better than Straumann
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
